Výsledky vyhledávání - Nathan Vastesaeger
- Zobrazuji výsledky 1 - 13 z 13
-
1
-
2
-
3
Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study Autor Asta Baranauskaitė, Helena Raffayová, Nikolay V. Kungurov, А. А. Кубанова, Algirdas Venalis, Laszlo Helmle, Shankar Srinivasan, Е. Л. Насонов, Nathan Vastesaeger
Vydáno 2011Artigo -
4
Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFA... Autor Joachim Sieper, Jan Lenaerts, J. Wollenhaupt, Martín Rudwaleit, Mazurov Vi, L. Myasoutova, S Park, Yeong Wook Song, R. Yao, D. K. Chitkara, Nathan Vastesaeger
Vydáno 2013Artigo -
5
Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-u... Autor Joachim Sieper, Jan Lenaerts, J. Wollenhaupt, Martín Rudwaleit, Mazurov Vi, L. Myasoutova, S Park, Yeong Wook Song, R. Yao, D. K. Chitkara, Nathan Vastesaeger
Vydáno 2013Artigo -
6
Spinal Radiographic Changes in Ankylosing Spondylitis: Association with Clinical Characteristics and Functional Outcome Autor Annelies Boonen, Bert Vander Cruyssen, K de Vlam, Serge Steinfeld, Clio Ribbens, Jan Lenaerts, Filip Van den Bosch, Herman Mielants, L Dewulf, Nathan Vastesaeger
Vydáno 2009Artigo -
7
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice Autor Bert Vander Cruyssen, C. Ribbens, A. Boonen, Herman Mielants, Kurt de Vlam, J. Lenaerts, Serge Steinfeld, Filip Van den Bosch, L Dewulf, Nathan Vastesaeger
Vydáno 2007Artigo -
8
Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery Autor Bert Vander Cruyssen, Elisa Muñoz-Gomáriz, Pilar Font, Juan Mulero, K de Vlam, Annelies Boonen, Janitzia Vázquez‐Mellado, D. Flores, Nathan Vastesaeger, Eduardo Collantes‐Estévez
Vydáno 2009Artigo -
9
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study Autor Bernard Combe, Bhaskar Dasgupta, Ingrid Louw, Sarvajeet Pal, J. Wollenhaupt, Cristiano A. F. Zerbini, André Beaulieu, Hendrik Schulze‐Koops, Patrick Durez, Ruji Yao, Nathan Vastesaeger, Haoling H. Weng
Vydáno 2013Artigo -
10
THU0155 Predictors of Low Disease Activity and Remission after One Dose of Golimumab in Patients with Rheumatoid Arthritis Autor Bhaskar Dasgupta, Bernard Combe, Patrick Durez, Hendrik Schulze‐Koops, Ingrid Louw, J. Wollenhaupt, Cristiano A. F. Zerbini, A. D. Beaulieu, R. Yao, Susan Huyck, Marcello Govoni, Hsu‐Huei Weng, Nathan Vastesaeger
Vydáno 2014Artigo -
11
Predicting the outcome of ankylosing spondylitis therapy Autor Nathan Vastesaeger, Désirée van der Heijde, Robert D. Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U. Rahman, Ben A. C. Dijkmans, Piet Geusens, Bert Vander Cruyssen, Eduardo Collantes‐Estévez, Joachim Sieper, Jürgen Braun
Vydáno 2011Artigo -
12
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab... Autor Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, René Westhovens, Patrick Durez, Filip Van den Bosch, Eric Veys, Herman Mielants, Luc S. De Clerck, Anne Peretz, Michel Malaise, Leon Verbruggen, Nathan Vastesaeger, Anja Geldhof, Luc Boullart, Filip De Keyser
Vydáno 2005Artigo -
13
Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab Autor Nathan Vastesaeger, Abraham García Kutzbach, Howard Amital, Karel Pavelká, María Alicia Lázaro, Robert J. Moots, J. Wollenhaupt, Cristiano A. F. Zerbini, Ingrid Louw, Bernard Combe, André Beaulieu, Hendrik Schulze‐Koops, Bhaskar Dasgupta, Bo Fu, Susan Huyck, Haoling H. Weng, Marinella Govoni, Patrick Durez
Vydáno 2016Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Physical therapy
Disease
Infliximab
Surgery
Ankylosing spondylitis
Rheumatoid arthritis
Gastroenterology
Psoriatic arthritis
BASDAI
Golimumab
Rheumatology
Adalimumab
BASFI
Computer science
Spondylitis
Adverse effect
Alternative medicine
Arthritis
Dermatology
Enthesitis
Environmental health
Epidemiology
Erythrocyte sedimentation rate
Etanercept
Logistic regression
Methotrexate
Pathology
Placebo